Source: Eur Respir J 2006; 27: 1076
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. SIMILOWSKI, A. AGUSTI, W. MACNEE AND B. SCHONHOFER. EUR RESPIR J 2006; 27: 390-396.. THE POTENTIAL IMPACT OF ANAEMIA OF CHRONIC DISEASE IN COPD.. Eur Respir J 2006; 27: 1076

Member's Comments

No comment yet.

Related content which might interest you: IMPACT OF CHRONIC ANEMIA ON THE EVOLUTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATION (COPDE) Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 PROGNOSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) ACCORDING TO STRENGTH IN UPPER LIMBS Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases Year: 2019 LIPID PEROXIDATION IN PATIENTS WITH COPD AND CHRONIC HEART FAILURE. Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 INTERSTITIAL LUNG DISEASE ASSOCIATED WITH CONNECTIVE TISSUE DISEASE (CTD-ILD): RETROSPECTIVE MULTICENTRIC STUDY Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment Year: 2020 QUALITY OF LIFE OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND THEIR CAREGIVERS Source: Virtual Congress 2020 – Organising respiratory disease management in primary care Year: 2020 HEART VARIABILITY IN THE PRESENCE OF PSYCHOLOGICAL STRESS AND QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care Year: 2020 PSYCHOLOGICAL FACTORS PREDICTIVE OF QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Source: Virtual Congress 2020 – Prognosis and integrated management of COPD Year: 2020 IMPACT OF TELEMONITORING ON PATIENTS WITH ADVANCED CHRONIC OBSTRUCTIVE PULMONARY DISEASE Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 FACTORS INFLUENCING PHARMACOLOGICAL TREATMENT IN COPD PATIENTS  ENROLED IN AN INTEGRATED DISEASE MANAGEMENT PROGRAMME (IDMP) Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018 USEFULNESS OF MIRNAS AS PREDICTORS OF LUNG CANCER IN PATIENTS WITH COPD. A PILOT SUTDY Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021 SYSTEMIC EFFECT OF CONTINUOUS TREATMENT WITH AZITHROMYCYN IN PATIENTS WITH SEVERE COPD AND FREQUENT EXACERBATIONS Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019 A RESPIRATORY TELEREHABILITATION PROGRAM AS MAINTENANCE  IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation Year: 2018 DIFFERENCES IN PSYCHOLOGICAL FACTORS BETWEEN PATIENTS WITH LEFT HEART FAILURE AND RIGHT HEART FAILURE ASSOCIATED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Source: Virtual Congress 2020 – Pulmonary embolism and beyond Year: 2020 SALBUTAMOL AND IPRATROPIUM BROMIDE ARE HIGH RISK FACTORS FOR ATRIAL ARRHYTHMIAS IN PATIENTS WITH COPD AND CVS DISEASES. Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 RATES OF LUNG FUNCTION DECLINE DIFFERS BETWEEN COPD PHENOTYPES Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 IMMUNOLOGICAL EVENTS AND SURVIVAL IN LUNG CANCER PATIENTS WITH COPD Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer Year: 2020 PULMONARY REHABILITATION EFFECT ON SYSTEMIC INFLAMMATION VALUES, APOB48, LIPIDEMIA AND CARDIOVASCULAR RISK IN PATIENTS WITH COPD Source: International Congress 2019 – Pulmonary rehabilitation for obstructive lung diseases Year: 2019 ORAL MORPHINE IS SAFE IN SYMPTOMATIC PATIENTS WITH FIBROTIC INTERSTITIAL LUNG DISEASES Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019 CYTOKINE RESPONSE AND CD14CD282 CELLS IN NON-SMOKERS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019 PSYCHOLOGICAL FACTORS PREDICTIVE OF QUALITY OF LIFE IN PATIENTS WITH INTERSTITIAL PULMONARY DISEASE Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020